title: Is the Ki-67 labelling index ready for clinical use?
authors.affiliation: Department of Gynaecology and Obstetrics, University Hospital Schleswig-Holstein, Christian-Albrechts-University, Kiel, Germany. Electronic address: jonat@email.uni-kiel.de.
authors.forename: W
authors.initials: W
authors.lastname: Jonat
authors.affiliation: Department of Gynaecology and Obstetrics, University Hospital Schleswig-Holstein, Christian-Albrechts-University, Kiel, Germany.
authors.forename: N
authors.initials: N
authors.lastname: Arnold
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000378:metabolism*; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D005260:Female; D006801:Humans; D019394:Ki-67 Antigen / Q000378:metabolism*; D025202:Molecular Diagnostic Techniques; D009376:Neoplasms, Hormone-Dependent / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D011237:Predictive Value of Tests; D013194:Staining and Labeling; D013629:Tamoxifen / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D018931:Antineoplastic Agents, Hormonal; D014408:Biomarkers, Tumor; D019394:Ki-67 Antigen; D013629:Tamoxifen